Savitr Capital

Overview

Savitr Capital is a private investment firm specializing in direct capital investments in complex situations, including company evolution, turnarounds, and restructurings. The firm emphasizes a long-term investment approach, partnering with management to create value and focusing its resources on a select number of investments at any given time. All capital is internal and permanent, providing the flexibility to support long-term growth and maximize value without the constraints of time. The firm's involvement typically includes serving as board members and being key partners to management. Savitr Capital often engages in the development of strategic plans, financing strategies, and execution, driving performance through the development of best practices and management milestones. Additionally, the firm focuses on the development of intellectual property strategies and the recruitment of key senior-level personnel. Savitr Capital's portfolio includes companies in sectors such as technology, energy, healthcare, and industrial manufacturing. The firm has made 14 investments, with notable exits including Heron Therapeutics, BioIQ, and Biora Therapeutics. The firm's investment strategy is characterized by a commitment to sustainability and responsible stewardship, aiming to achieve superior risk-adjusted returns while investing in companies poised for leadership in clean and renewable energy. Please note that while Savitr Capital is based in the United States, it has a global investment perspective, focusing on companies with the potential for significant impact in their respective industries. The firm's approach combines operator-first insights with a thematic focus on sustainability and innovation, reflecting a data-driven strategy to identify high-growth opportunities.